» Articles » PMID: 10828887

Cdc25A Stability is Controlled by the Ubiquitin-proteasome Pathway During Cell Cycle Progression and Terminal Differentiation

Overview
Journal Oncogene
Date 2000 Jun 1
PMID 10828887
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Members of the cdc25 family are protein phosphatases that play pivotal roles in cell cycle progression. Cdc25A has been shown to be a critical regulator of the G1/S transition of mammalian cells and to be a myc-target gene with oncongenic properties. We investigated the regulation of cdc25A during terminal differentiation using myeloblastic leukemia M1 cells, that can be induced to undergo differentiation into macrophages by interleukin-6 (IL-6) treatment. In this report it is shown that cdc25A protein is degraded by the ubiquitin-proteasome machinery in both terminally differentiating and cycling cells. Cdc25A was found to have two major peaks of accumulation during cell cycle progression, one in G1 and the other in S/G2. Evidence was obtained that degradation of cdc25A by the ubiquitin-proteasome machinery in terminally differentiating myeloid cells is accelerated compared to cycling cells. Moreover, deregulated expression of c-myc in M1 cells, which had been previously shown to block terminal differentiation, was also found to block IL-6 induced degradation of cdc25A.

Citing Articles

mA modification enhances the stability of promotes tumorigenicity of esophagogastric junction adenocarcinoma via cell cycle.

Pan Y, Feng H, Zhou J, Zhang W, Liu Y, Zheng J Int J Biol Sci. 2024; 20(11):4209-4221.

PMID: 39247830 PMC: 11379066. DOI: 10.7150/ijbs.98535.


Identification of VWA5A as a novel biomarker for inhibiting metastasis in breast cancer by machine-learning based protein prioritization.

Koh J, Jeong D, Park S, Han D, Kim D, Kim H Sci Rep. 2024; 14(1):2459.

PMID: 38291227 PMC: 10828438. DOI: 10.1038/s41598-024-53015-1.


Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle.

Luu A, Cadieux M, Wong M, Macdonald R, Jones R, Choi D Int J Mol Sci. 2022; 23(6).

PMID: 35328679 PMC: 8953151. DOI: 10.3390/ijms23063256.


Theranostic Interpolation of Genomic Instability in Breast Cancer.

Rasool R, Ullah I, Mubeen B, Alshehri S, Imam S, Ghoneim M Int J Mol Sci. 2022; 23(3).

PMID: 35163783 PMC: 8836911. DOI: 10.3390/ijms23031861.


Ubiquitin-Specific Protease 29 Regulates Cdc25A-Mediated Tumorigenesis.

Chandrasekaran A, Woo S, Sarodaya N, Rhie B, Tyagi A, Das S Int J Mol Sci. 2021; 22(11).

PMID: 34071237 PMC: 8198132. DOI: 10.3390/ijms22115766.